The Functional Interplay Between the t(9;22)-Associated Fusion Proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-Positive Acute Lymphatic Leukemia-Reference-Cited by-同舟云学术

The Functional Interplay Between the t(9;22)-Associated Fusion Proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-Positive Acute Lymphatic Leukemia

Published:2015-04-28 Issue:4 Volume:11 Page:e1005144
ISSN:1553-7404
Container-title:PLOS Genetics
language:en
Short-container-title:PLoS Genet

Author:

Rafiei Anahita,Mian Afsar Ali,Döring Claudia,Metodieva Anna,Oancea Claudia,Thalheimer Frederic B.,Hansmann Martin Leo,Ottmann Oliver Gerhard,Ruthardt Martin

Publisher

Public Library of Science (PLoS)

Subject

Cancer Research,Genetics(clinical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics

Reference60 articles.

1. The biology of chronic myeloid leukemia;S Faderl;N Engl J Med,1999

2. Does BCR/ABL1 positive acute myeloid leukaemia exist?;EP Nacheva;Br J Haematol,2013

3. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis;CP Soupir;Am J Clin Pathol,2007

4. Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia;DJ Barnes;Acta Haematol,2002

5. The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial;G Cimino;Haematologica,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly precise breakpoint detection of chromosome balanced translocation in chronic myelogenous leukaemia: Case series;Journal of Cellular and Molecular Medicine;2022-07-28

2. The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significance;Life Sciences;2022-05

3. Oncogene-independent resistance in Philadelphia chromosome - positive (Ph+) acute lymphoblastic leukemia (ALL) is mediated by activation of AKT/mTOR pathway;Neoplasia;2021-09

4. Oncogenic Kinase Cascades Induce Molecular Mechanisms That Protect Leukemic Cell Models from Lethal Effects of De Novo dNTP Synthesis Inhibition;Cancers;2021-07-10

5. Milestone Histories and Paradigmatic Genetic Discoveries of Chronic Myeloid Leukemia (CML);Rare Diseases;2020-03-25